Supplementary Figure 18 from Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma

Authors: Justin D. Clubb, Ryan M. Shih, Torahito A. Gao et al.

Publication:

Published: Unknown date

Source: Crossref

Back to Search View Original Cite This Article

Abstract

<jats:p><p>Fig. S18. Treatment with pooled CAR-12.DR18 plus CAR-αVEGF T cells does not significantly change peripheral blood cytokine levels compared to CAR-12.DR18T cells.</p></jats:p>

Keywords

pfig treatment pooled car12dr18 carαvegf

Supplementary Figure 18 from Armored Chimeric Antigen Receptor T-cell Therapy Targets Antigen-Heterogeneous Glioma

Abstract

Keywords

Related Articles

Supplementary Table S8 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer

Supplementary Figure S9 from HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer

Figure S8 from MPND Loss Epigenetically Activates TGFβ/SMAD3 Signaling to Drive Tumor Progression and Metastasis in Non–Small Cell Lung Cancer

Table S11 from GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma

Table S1 from GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma